Résumé
Objective To investigate clinical effect of shenlingbaizhu powder combined with flupentixol and melitracen tablets in treatment of spleen deficiency and liver stagnation type IBS-D.Methods 70 cases of liver depression and spleen deficiency type diarrhea predominant IBS patients were selected and in accordance with the principle of random number were divided into observation group and control group, 35 cases in each group, control group was treated with shenlingbaizhupowder treatment, observation group was given shenlingbaizhu powder combined with flupentixol and melitracen tablets treatment,clinical curative effect between two groups was compared.Results The effective rate of the observation group was 91.43%, was higher than that of control group 77.14% (P<0.05).After treatment, the SDS score and SAS score of the two groups were improved (P<0.05), and the improvement effect of observation group was more obvious ( P <0.05 ) .Conclusion Shenlingbaizhu powder combined with flupentixol and melitracen tablets has good effect in treatment of liver depression and spleen deficiency type IBS-D, it is worthy of clinical application.
Résumé
Objective To observe clinical effect of treating infantile chronic diarrhea with Shenlingbaizhu powder and smecta.Methods 82 cases with chronic diarrhea were randomly divided into a control group and a treatment group.The control group was taken smecta orally,and the treatment group was taken Shenlingbaizhu powder together with smecta orally.10 days constitute a treatment course.Atier two courses,the therapeutic effects were observed in the treatment group and the control group respectively.Results The total effective rate was 92.9%and 77.5%in the treatment group the control group respectively,showing a significant difference(P＜0.05).Conclusion The treatment of infantile chronic diarrhea with Shenlingbaizhu powder and smecta has a better effect.